A detailed history of Inspire Investing, LLC transactions in Xencor Inc stock. As of the latest transaction made, Inspire Investing, LLC holds 20,530 shares of XNCR stock, worth $514,071. This represents 0.04% of its overall portfolio holdings.

Number of Shares
20,530
Previous 18,643 10.12%
Holding current value
$514,071
Previous $352,000 17.05%
% of portfolio
0.04%
Previous 0.04%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$15.7 - $21.65 $29,625 - $40,853
1,887 Added 10.12%
20,530 $412,000
Q2 2024

Aug 12, 2024

BUY
$18.21 - $24.5 $46,672 - $62,793
2,563 Added 15.94%
18,643 $352,000
Q1 2024

May 07, 2024

SELL
$18.65 - $26.52 $43,491 - $61,844
-2,332 Reduced 12.67%
16,080 $355,000
Q4 2023

Feb 12, 2024

BUY
$16.53 - $21.42 $51,970 - $67,344
3,144 Added 20.59%
18,412 $390,000
Q3 2023

Oct 26, 2023

BUY
$20.08 - $25.39 $306,581 - $387,654
15,268 New
15,268 $307,000
Q2 2020

Aug 12, 2020

SELL
$27.76 - $33.42 $333 - $401
-12 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$20.69 - $37.79 $248 - $453
12 New
12 $0
Q1 2018

Apr 13, 2018

SELL
$21.18 - $33.78 $1,101 - $1,756
-52 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$19.29 - $24.83 $1,003 - $1,291
52
52 $1,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.49B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.